Author:
Leving Marika,Wouters Hans,de la Hoz Alberto,Bosnic-Anticevich Sinthia,Dekhuijzen Richard,Gardev Asparuh,Lavorini Federico,Meijer Jiska,Price David,Rodríguez Miguel Román,Tsiligianni Ioanna,Usmani Omar,Wijnsma Birgit,Kocks Janwillem
Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine,Respiratory Care
Reference52 articles.
1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2021 report). 2020 [cited February 2 2021]. https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf.
2. Levy ML, Carroll W, Izquierdo Alonso JL, Keller C, Lavorini F, Lehtimäki L. Understanding dry powder inhalers: Key technical and patient preference attributes. Adv Ther. 2019;36(10):2547–57.
3. Ding B, Small M, Scheffel G, Holmgren U. Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma–COPD overlap syndrome consulting for routine care. Int J Chron Obstruct Pulmon Dis. 2018;13:927–37.
4. Berkenfeld K, Lamprecht A, McConville JT. Devices for dry powder drug delivery to the lung. AAPS PharmSciTech. 2015;16(3):479–90.
5. Ghosh S, Ohar JA, Drummond MB. Peak inspiratory flow rate in chronic obstructive pulmonary disease: Implications for dry powder inhalers. J Aerosol Med Pulm Drug Deliv. 2017;30(6):381–7.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献